SECURITIES
PURCHASE AGREEMENT


 


This
SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of October 4, 2016, among ICTV
Brands Inc., a Nevada corporation (the “Company”), and the investors listed on the Schedule of Investors
attached hereto as Exhibit A and identified on the signature pages hereto (each, an “Investor” and collectively,
the “Investors”). The Company and the Investors are collectively referred to in this Agreement as the “Parties,”
and each a “Party.”


 


RECITALS


 


Subject
to the terms and conditions set forth in this Agreement and in reliance upon the applicable exemptions from securities registration
under the Securities Act (as defined below), the Company desires to issue and sell to each Investor, and each Investor, severally
and not jointly, desires to purchase from the Company certain securities of the Company, as more fully described in this Agreement.


 


AGREEMENT


 


NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration
the receipt and adequacy of which are hereby acknowledged, the Company and the Investors agree as follows:


 


ARTICLE
1.


DEFINITIONS


 


1.1. Definitions.
In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms shall
have the meanings indicated in this Section 1.1:


 


“Action”
as to any Person, means any action, suit, inquiry, notice of violation, proceeding (including any partial proceeding such
as a deposition) or investigation pending or threatened in writing against or affecting such Person, any of such Person’s
Subsidiaries or any of such Person’s or such Subsidiaries’ respective properties, before or by any Governmental Body,
arbitrator, regulatory authority (federal, state, county, local or foreign), stock market, stock exchange or trading facility.


 


“Business”
means the business currently conducted by the Company and/or its Subsidiaries as disclosed in the SEC Reports.


 


“Business
Day” means any day except Saturday, Sunday and any day which is a federal legal holiday or a day on which banking institutions
in the Commonwealth of Pennsylvania are authorized or required by law or other governmental action to close.


 


“Commission”
means the Securities and Exchange Commission.


 




    	 	 	 



    	 



    


 


“Common
Stock” means the common stock of the Company, par value $0.001 per share, and any securities into which such common
stock may hereafter be reclassified or for which it may be exchanged as a class.


 


“Company’s
Knowledge” means the actual knowledge of Kelvin Claney, Richard Ransom and Ryan LeBon after reasonable inquiry.


 


“Escrow
Account” means the IOLTA attorney trust account of the Escrow Agent where funds representing the Investor’s aggregate
Purchase Price shall be held pending the First Closing and simultaneous PHMD Closing.


 


“Escrow
Agent” means Bevilacqua PLLC.


 


“Escrow
Agreement” means that certain escrow agreement dated on or about the date hereof among the Company, the Escrow Agent,
the Investors and the other parties thereto.


 


“Exchange
Act” means the Securities Exchange Act of 1934, as amended.


 


“GAAP”
means U.S. generally accepted accounting principles.


 


“Governmental
Body” means any: (a) nation, state, commonwealth, province, territory, county, municipality, district or other jurisdiction
of any nature; (b) federal, state, local, municipal, foreign or other government; or (c) governmental or quasi-governmental authority
of any nature (including any governmental or administrative division, department, agency, commission, instrumentality, official,
organization, unit, body or entity) and any court or other tribunal.


 


“Investment
Amount” means, with respect to each Investor, the Investment Amount indicated on such Investor’s signature page
to this Agreement, which is also reflected on the Schedule of Investors attached hereto as Exhibit A.


 


“Intellectual
Property” means the Company’s patents, patent applications, provisional patents, trademarks, service marks, trade
names, trademark registrations, service mark registrations, copyrights, licenses, formulae, mask works, customer lists, internet
domain names, know-how and other intellectual property, including trade secrets and other unpatented and/or unpatentable proprietary
or confidential information, systems, procedures or registrations or applications relating to the same.


 


“Investor”
means any person who purchases Shares in the Offering pursuant to this Agreement.


 


“Irrevocable
Transfer Agent Instructions” means the Irrevocable Transfer Agent Instructions executed by the Company and delivered
to and acknowledged in writing by the Transfer Agent, in form acceptable to the Investors.


 


“Legal
Requirement” means any federal state, local, municipal, foreign or other law, statute, constitution, principle of common
law, resolution, ordinance, code, edict, decree, rule, regulation, ruling or requirement issued, enacted, adopted, promulgated,
implemented or otherwise put into effect by or under the authority of any Governmental Body (or under the authority of any national
securities exchange upon which the Common Stock is then listed or traded). Reference to any Legal Requirement means such Legal
Requirement as amended, modified, codified, replaced or reenacted, in whole or in part, and in effect from time to time, and reference
to any section or other provision of any Legal Requirement means that provision of such Legal Requirement from time to time in
effect and constituting the substantive amendment, modification, codification, replacement or reenactment of such section or other
provision.


 




    	 	2 	 



    	 



    


 


“Lien”
means any interest in Property securing an obligation owed to a Person whether such interest is based on the common law, statute
or contract, and including but not limited to a security interest arising from a mortgage, lien, title claim, assignment, encumbrance,
adverse claim, contract of sale, pledge, conditional sale or trust receipt or a lease, consignment or bailment for security purposes.
The term “Lien” includes but is not limited to mechanics’, materialmens’, warehousemens’ and carriers’
liens and other similar encumbrances.


 


“Maximum
Amount” means $7,000,000.


 


“Material
Adverse Effect” means any event, change, circumstance, effect or other matter that has, or could reasonably be expected
to have, either individually or in the aggregate with all other events, changes, circumstances, effects or other matters, with
or without notice, lapse of time or both, (i) a material and adverse effect on the legality, validity or enforceability of any
Transaction Document, the PHMD APA or the PHMD Transaction Documents, (ii) a material and adverse effect on the results of operations,
assets, properties, business or condition (financial or otherwise) of the Company individually or the Company and the Subsidiaries,
taken as a whole, or (iii) a material and adverse impairment to the Company’s ability to perform on a timely basis its obligations
under any Transaction Document, the PHMD APA or the PHMD Transaction Documents provided, however, that any effect(s) arising
from or relating to any of the following shall not be deemed, either alone or in combination, to constitute, and shall not be
taken into account in determining whether there has been or will be, a Material Adverse Effect: (A) conditions affecting the industries
in which the Business operates (which effect(s), in each case, do not disproportionately affect the Business relative to other
companies conducting businesses similar to the Business); (B) general economic, financial market or geopolitical conditions (which
effect(s), in each case, do not disproportionately affect the Business relative to other companies conducting businesses similar
to the Business); (C) any change in accounting rules (including GAAP), or the enforcement, implementation or interpretation thereof,
after the date hereof; or (D) any effect caused by, relating to or resulting from the announcement or pendency of the transactions
contemplated by this Agreement.


 


“Offering”
means the offering and sale of the Shares pursuant to this Agreement.


 


“Outside
Date” means the outside date for termination under the PHMD APA as specified in Section 9.1(c) and 9.1(d) of the PHMD
APA as the same may be amended from time to time in accordance with the PHMD APA.


 


“OTC
Market” means the OTC Bulletin Board system, the OTCQX market operated by OTC Markets and the OTCQB market operated
by OTC Markets Group.


 




    	 	3 	 



    	 



    


 


“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited
liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.


 


“PHMD
APA” means that certain asset purchase agreement, dated October 4, 2016, among the Company, ICTV Holdings, Inc., a wholly-owned
subsidiary of the Company, PhotoMedex, Inc., Radiancy, Inc., PhotoTherapeutics Ltd and Radiancy (Israel) Limited.


 


“PHMD
Closing” means the closing of the transactions contemplated by the PHMD APA.


 


“PHMD
Transaction Documents” means any and all transaction documents relating to the PHMD APA and the transactions contemplated
thereby.


 


“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding,
such as a deposition), whether commenced or, to the Company’s Knowledge, threatened.


 


“Property”
means any interest in any kind of property or asset, whether real, personal or mixed, or tangible or intangible.


 


“Registration
Rights Agreement” means the Registration Rights Agreement, to be dated as of the Closing Date, among the Company and
the Investors in the form of Exhibit B hereto.


 


“Securities
Act” means the Securities Act of 1933, as amended.


 


“Shares”
means the shares of Common Stock.


 


“Short
Sales” include, without limitation, all “short sales” as defined in Rule 200 promulgated under Regulation
SHO under the Exchange Act and all types of direct and indirect stock pledges, forward sale contracts, options, puts, calls, swaps
and similar arrangements (including on a total return basis), and sales and other transactions through non-US broker dealers or
foreign regulated brokers.


 


“Subsidiary”
means any “significant subsidiary” as defined in Rule 1-02(w) of the Regulation S-X promulgated by the Commission
under the Exchange Act.


 


“Trading
Day” means: (i) a day on which the Common Stock is traded on a Trading Market (other than an OTC Market), or (ii) if
the Common Stock is not listed on a Trading Market (other than an OTC Market), a day on which the Common Stock is traded in the
over the counter market, as reported by OTCQB, or (iii) if the Common Stock is not quoted on any Trading Market, a day on which
the Common Stock is quoted in the over the counter market as reported by the Pink Sheets LLC (or any similar organization or agency
succeeding to its functions of reporting prices); provided, that in the event that the Common Stock is not listed or quoted as
set forth in (i), (ii) and (iii) hereof, then Trading Day shall mean a Business Day.


 




    	 	4 	 



    	 



    


 


“Trading
Market” means any of the New York Stock Exchange, the NYSE MKT, the NASDAQ Global Select Market, the NASDAQ Global Market,
the NASDAQ Capital Market, an OTC Market or any other market on which the Common Stock is listed or quoted for trading on the
date in question.


 


“Transaction
Documents” means this Agreement, the Registration Rights Agreement, the Escrow Agreement and any other documents or
agreements executed in connection with the transactions contemplated hereunder.


 


“Transfer
Agent” means Capital Transfer Agency, Inc., the current transfer agent of the Company with a mailing address of 121
Richmond Street, West, Suite 401, Toronto, ON M5H 2K1 and a facsimile number of (416) 350-5007, and any successor transfer agent
of the Company.


 


“U.S.
Investor” means an Investor who is resident in the United States of America.


 


ARTICLE
2.


PURCHASE
AND SALE


 


2.1. Subscription
for Shares by the Investors. Subject to the terms and conditions of this Agreement, on the Closing Date (as defined
below), each of the Investors shall severally, and not jointly, purchase, and the Company shall sell and issue to each
Investor, the Shares, as specified on the Schedule of Investors attached hereto as Exhibit A, at a purchase
price of $0.34 per Share.


 


2.2. Closing.


 


(a)First
Closing. Subject to the terms and conditions set forth in this Agreement, the Company shall issue and sell to each Investor,
and each such Investor shall, severally and not jointly, purchase from the Company, simultaneously with the PHMD Closing (the
“First Closing Date”), such number of Shares set forth on the respective signature pages attached hereto, which
will be reflected opposite such Investor’s name on Exhibit A (the “First Closing”).


 


(b)Subsequent
Closing(s). In the event that the Maximum Amount is not raised at the First Closing, the Company may have one or more subsequent
Closings of the Offering (each, a “Subsequent Closing”) until the first to occur of: (i) the Maximum Amount
being raised and (ii) the Outside Date. At each Subsequent Closing, the Company agrees to issue and sell to each Investor participating
in such Subsequent Closing who executes a signature page hereto, and each such Investor agrees, severally and not jointly, to
purchase from the Company such number of Shares set forth on such Investor’s signature pages attached hereto. There may
be more than one Subsequent Closing; provided, however, that the final Subsequent Closing shall take place on or
before the Outside Date. The date of any Subsequent Closing is hereinafter referred to as a “Subsequent Closing Date”).


 




    	 	5 	 



    	 



    


 


(c)Closing.
The First Closing and any applicable Subsequent Closings are each referred to in this Agreement as a “Closing.”
The First Closing Date and any Subsequent Closing Date are sometimes referred to herein as a “Closing Date.”
The Closing at which the Maximum Amount is raised, or which is the last Closing prior to the Outside Date, is referred to as the
“Final Closing.” The date of the Final Closing is referred to as the “Final Closing Date.”
All Closings shall occur remotely via the exchange of documents and signatures or as otherwise agreed to by the Parties.


 


2.3.
Signing and Closing Deliveries.


 


(a)Immediately
upon signing this Agreement each Investor and the Company shall execute and deliver the Escrow Agreement to each other, the Escrow
Agent and the other parties to the Escrow Agreement against delivery by the Escrow Agent and such other parties of an executed
copy of the Escrow Agreement and each Investor shall deposit such Investor’s Investment Amount into the Escrow Account with
the Escrow Agent in accordance with the terms of the Escrow Agreement pending the First Closing.


 


(b)Subject
to the provisions of this Section 2.3, at each Closing, the Company shall deliver or cause to be delivered to each Investor participating
in such Closing, against the delivery by such Investor of the Investment Amount from the Escrow Account or otherwise, the following
(the “Company Deliverables”):


 


(i)duly
executed Irrevocable Transfer Agent Instructions acknowledged in writing by the Transfer Agent for the requisite number of Shares
to be delivered to such Investor at such Closing;


 


(ii)a
certificate executed on behalf of the Company by its Chief Executive Officer or its Chief Financial Officer, dated as of the applicable
Closing Date, certifying to the fulfillment of the conditions specified in Article 5 (the “Company Officer Certificate”);


 


(iii)a
certificate executed on behalf of the Company by its secretary dated as of the First Closing Date, certifying the resolutions
adopted by the board of directors of the Company approving the transactions contemplated by this Agreement, the other Transaction
Documents, the issuance of the Shares, the transactions contemplated by the PHMD APA and PHMD Transaction Documents and certifying
as to the signatures and authority of persons signing the Transaction Documents, the PHMD APA and the PHMD Transaction Documents
and related documents on behalf of the Company (the “Company Secretary Certificate”). The foregoing certificate
shall only be required to be delivered on the First Closing Date, unless any material information contained in the certificate
has changed;


 


(iv)this
Agreement, duly executed by the Company;


 


(v)the
Registration Rights Agreement, duly executed by the Company; and


 


(vi)a
copy of the PHMD APA and PHMD Transaction Documents duly signed by the parties thereto and certified by the Company’s secretary.


 




    	 	6 	 



    	 



    


 


(c)By
the applicable Closing, each Investor shall deliver or cause to be delivered the agreements specified in Section 5.2(e), each
duly signed by such Investor (collectively, the “Investor Deliverables”).


 


(d)At
each Closing, each Investor participating in such Closing shall deliver or cause to be delivered, including through the provision
of written directions to the Escrow Agent to deliver, to the Company, its Investment Amount, in United States dollars and in immediately
available funds, by wire transfer to the account designated in writing by the Company for such purpose.


 


2.4. The
Registration Rights Agreement. The Registration Rights Agreement shall contain the terms and conditions and be in the
form attached hereto as Exhibit B.


 


2.5. Use
of Proceeds. The Company hereby covenants and agrees that the proceeds from the sale of Shares net of expenses shall be
used to fund all or a portion of the purchase price under the PHMD APA.


 


ARTICLE
3.


REPRESENTATIONS
AND WARRANTIES


 


3.1. Representations
and Warranties of the Company. Except as set forth in the corresponding section of the Disclosure Schedules delivered
concurrently herewith, the Company hereby makes the following representations and warranties as of the date hereof and as of
the Closing Date to each Investor:


 


(a)Subsidiaries.
The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary of the Company
free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued
and are fully paid, nonassessable and free of preemptive and similar rights to subscribe for or purchase securities.


 


(b)Organization
and Qualification. The Company and each Subsidiary are duly incorporated or otherwise organized, validly existing and in good
standing under the laws of the jurisdiction of its incorporation or organization (as applicable), with the requisite power and
authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor
any Subsidiary is in violation of any of the provisions of its respective certificate or articles of incorporation, bylaws or
other organizational or charter documents. The Company and each Subsidiary are duly qualified to conduct its respective businesses
and are in good standing in each jurisdiction in which the nature of the business conducted or property owned by it makes such
qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not, individually
or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect.


 




    	 	7 	 



    	 



    


 


(c)Authorization;
Enforcement. The Company has the requisite corporate and other power and authority to enter into and to consummate the transactions
contemplated by each of the Transaction Documents, the PHMD APA and the PHMD Transaction Documents and otherwise to carry out
its obligations thereunder. The execution and delivery of each of the Transaction Documents, the PHMD APA and the PHMD Transaction
Documents by the Company and the consummation by it of the transactions contemplated thereby have been duly authorized by all
necessary action on the part of the Company, and no further action is required by the Company or any Subsidiary in connection
therewith. Each Transaction Document, the PHMD APA and each PHMD Transaction Document has been (or upon delivery will have been)
duly executed by the Company and, when delivered in accordance with its terms, will constitute the valid and binding obligation
of the Company, enforceable against the Company in accordance with its terms, except as such enforceability may be limited by
applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally
the enforcement of, creditors’ rights and remedies or by other equitable principles of general application.


 


(d)No
Conflicts. Except as set forth on Schedule 3.1(d), the execution, delivery and performance of each of the Transaction
Documents, the PHMD APA and each PHMD Transaction Document by the Company and the consummation by the Company of the transactions
contemplated thereby do not and will not (i) conflict with or violate any provision of the Company’s or any Subsidiary’s
certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute
a default (or an event that with notice or lapse of time or both would become a default) under, or give to others any rights of
termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any material agreement,
credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which
the Company or any Subsidiary is a party or by which any property or asset of the Company or a Subsidiary is bound or affected,
or (iii) result in a material violation of any Legal Requirement, order, judgment, injunction, decree or other restriction of
any Governmental Body to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected.


 


(e)Filings,
Consents and Approvals. Except as set forth on Schedule 3.1(e), neither the Company nor any Subsidiary is required
to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any Governmental
Body or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other
than (i) the filing with the Commission of one or more registration statements in accordance with the requirements of the Registration
Rights Agreement, (ii) filings required by state securities laws, (iii) the filing of a Notice of Sale of Securities on Form D
with the Commission under Regulation D of the Securities Act, (iv) those that have been made or obtained prior to the date of
this Agreement, and (v) other post-closing securities filings or notifications required to be made under federal or state securities
laws.


 


(f)Issuance
of the Shares. The Shares are duly authorized and, when issued and paid for in accordance with the Transaction Documents,
will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens.


 




    	 	8 	 



    	 



    


 


(g)Capitalization.


 


(i)Schedule
3.1(g) sets forth as of the date hereof (a) the authorized capital stock of the Company; (b) the number and class of shares
of capital stock issued and outstanding; (c) the number and class of shares of capital stock issuable pursuant to the Company’s
stock incentive plans or agreements; and (d) the number and class of shares of capital stock issuable and reserved for issuance
pursuant to securities exercisable for, or convertible into or exchangeable for any shares of capital stock of the Company and
a description of the number and rights of such securities.


 


(ii)All
of the issued and outstanding shares of the Company’s capital stock have been duly authorized and validly issued and are
fully paid, nonassessable and free of pre-emptive rights and were issued in full compliance with applicable state and federal
securities law and any rights of third parties.


 


(iii)No
Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions
contemplated by the Transaction Documents.


 


(iv)Except
as described on Schedule 3.1(g), there are no outstanding (i) shares of capital stock or voting securities of the Company
or (ii) options, warrants, script rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities,
rights or obligations convertible into or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares
of capital stock or voting securities or securities convertible into or exchangeable for capital stock or voting securities of
the Company, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become
bound to issue additional shares of capital stock or voting securities of the Company, or securities or rights convertible or
exchangeable into shares of capital stock or voting securities of the Company (the items in clauses (i) and (ii) being referred
to collectively as the “Company Securities”). There are no outstanding obligations of the Company or any Subsidiary
to repurchase, redeem or otherwise acquire any Company Securities.


 


(v)The
issuance and sale of the Shares will not obligate the Company to issue shares of Common Stock or other securities to any Person
(other than the Investors) and will not result in a right of any holder of Company securities to adjust the exercise, conversion,
exchange or reset price under such securities.


 


(vi)Except
as described on Schedule 3.1(g), there are no voting agreements, buy-sell agreements, option or right of first purchase
agreements or other agreements of any kind among the Company and any of the securities-holders of the Company relating to the
securities of the Company held by them.


 


(vii)No
Person has the right to require the Company to register any securities of the Company under the Securities Act, whether on a demand
basis or in connection with the registration of securities of the Company for its own account or for the account of any other
Person.


 




    	 	9 	 



    	 



    





 


(h)SEC
Reports; Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents and registration
statements required to be filed by it under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d)
thereof, for the twelve months preceding the date hereof (or such shorter period as the Company was required by law to file such
reports) (the foregoing materials being collectively referred to herein as the “SEC Reports” and, together
with the Schedules to this Agreement (if any), the “Disclosure Materials”) on a timely basis or has timely
filed and received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any
such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities
Act and the Exchange Act and the rules and regulations of the Commission promulgated thereunder, and none of the SEC Reports,
when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein
or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading.
The financial statements of the Company and each Subsidiary included in the SEC Reports complied in all material respects with
applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time
of filing. Such financial statements have been prepared in accordance with GAAP, and fairly present in all material respects the
financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations
and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial year-end audit
adjustments. There is no transaction, arrangement, or other relationship between the Company or any Subsidiary and an unconsolidated
or other off balance sheet entity that is not disclosed in its financial statements that should be disclosed in accordance with
GAAP.


 


(i)Material
Changes. Except as described on Schedule 3.1(i) or in the SEC Reports, since the date of the latest audited financial
statements included within the SEC Reports:


 


(i)There
has been no event or circumstance of any nature whatsoever that has resulted in, or could reasonably be expected to result in,
a Material Adverse Effect; or


 


(ii)Except
for this Agreement and the other Transaction Documents, there has been no transaction, event, action, development, payment, or
other matter of any nature whatsoever entered into by the Company that requires disclosure in an SEC Report which has not been
so disclosed.


 


(j)No
Undisclosed Material Liabilities. There are no liabilities of the Company or any Subsidiary of any kind whatsoever, whether
accrued, contingent, absolute, determined, determinable or otherwise, and there is no existing condition, situation or set of
circumstances which could reasonably be expected to result in such a liability, other than liabilities provided for in the unaudited
consolidated balance sheet of the Company and the Subsidiaries as of June 30, 2016.


 


(k)Litigation.
There is no Action which (i) adversely affects or challenges the legality, validity or enforceability of any of the PHMD APA or
other PHMD Transaction Documents, Transaction Documents or the Shares or (ii) except as disclosed in the SEC Reports, could, if
there were an unfavorable decision, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse
Effect. Neither the Company nor any Subsidiary, nor to the Company’s Knowledge, any director or officer thereof (in his
or her capacity as such), is or has been the subject of any Action involving a claim of violation of or liability under federal
or state securities laws or a claim of breach of fiduciary duty, except as disclosed in the Disclosure Materials. There has not
been, and to the Company’s Knowledge, there is not pending or contemplated any investigation by the Commission involving
the Company or any current or former director or officer of the Company (in his or her capacity as such). The Commission has not
issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary
under the Exchange Act or the Securities Act.


 




    	 	10 	 



    	 



    


 


(l)Compliance.
Neither the Company nor any Subsidiary (i) is in default under or in violation of (and no event has occurred that has not been
waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has
the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, (A) the PHMD
APA or any of the PHMD Transaction Documents, or (B) any indenture, loan or credit agreement or any other material agreement or
instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has
been waived), (ii) is in violation of any order of any court, arbitrator or Governmental Body, or (iii) is or has been in material
violation of any statute, rule or regulation of any governmental authority, including without limitation all foreign, federal,
state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and
employment and labor matters. The Company is in compliance with all effective requirements of the Sarbanes-Oxley Act of 2002,
as amended, and the rules and regulations thereunder, that are applicable to it.


 


(m)Title
to Assets. The Company and the Subsidiaries own, lease or otherwise have a valid right to use, all real property that is material
to the Business, good and marketable title in fee simple to all personal property owned by them that is material to the Business
and good and marketable title in all personal property owned by them that is material to the Business, in each case free and clear
of all Liens, except for Liens as do not materially affect the value of such property and do not materially interfere with the
use made and proposed to be made of such property by the Company and the Subsidiaries and Liens for the payment of federal, state
or other taxes, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under
lease by the Company and the Subsidiaries that are material to the Business are held by them under valid, subsisting and enforceable
leases of which the Company and the Subsidiaries are in compliance in all material respects.


 


(n)Taxes.
The Company has timely and properly filed all tax returns required to be filed by it for all years and periods (and portions thereof)
for which any such tax returns were due. All such filed tax returns are accurate in all material respects. The Company has timely
paid all taxes due and payable (whether or not shown on filed tax returns). There are no pending assessments, asserted deficiencies
or claims for additional taxes that have not been paid. There have been no audits or examinations of any tax returns by any Governmental
Body, and the Company has not received any notice that such audit or examination is pending or contemplated. No claim has been
made by any Governmental Body in a jurisdiction where the Company does not file tax returns that it is or may be subject to taxation
by that jurisdiction. To the Knowledge of the Company, no state of facts exists or has existed which would constitute grounds
for the assessment of any penalty or any further tax liability beyond that shown on the respective tax returns. There are no outstanding
agreements or waivers extending the statutory period of limitation for the assessment or collection of any tax.


 




    	 	11 	 



    	 



    


 


(o)Intellectual
Property. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark
applications, service marks, trade names, copyrights, licenses and other similar rights (collectively, the “Intellectual
Property Rights”) that are necessary or material for use in connection with the Business as described in the SEC Reports.
Neither the Company nor any Subsidiary has received a written notice that the Intellectual Property Rights used by the Company
or any Subsidiary violates or infringes upon the rights of any Person. Except as set forth in the SEC Reports, to the Company’s
Knowledge, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any
of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable steps to protect the Company’s
and its Subsidiaries’ rights in their Intellectual Property Rights and confidential information (the “Confidential
Information”). Each employee, consultant and contractor who has had access to Confidential Information which is necessary
for the conduct of the Business as currently conducted or as currently proposed to be conducted has executed an agreement to maintain
the confidentiality of such Confidential Information and has executed appropriate agreements that are substantially consistent
with the Company’s standard forms thereof. Except under confidentiality obligations, there has been no material disclosure
of any of the Company’s or its Subsidiaries’ Confidential Information to any third party.


 


(p)Certain
Fees. No brokerage or finder’s fees or commissions are or will be payable by the Company to any broker, financial advisor
or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated
by this Agreement.


 


3.2. Representations
and Warranties of the Investors. Each Investor hereby, for itself and for no other Investor, makes the
following representations and warranties as of the date hereof and as of the Closing Date to the Company:


 


(a)Organization;
Authority. If such Investor is a business entity, such Investor is an entity duly organized, validly existing and in good
standing under the laws of the jurisdiction of its organization with the requisite corporate or partnership power and authority
to enter into and to consummate the transactions contemplated by the Transaction Documents to which it is a party or a signatory
and otherwise to carry out its obligations thereunder. The execution, delivery and performance by such Investor of the transactions
contemplated by this Agreement has been duly authorized by all necessary corporate or, if such Investor is not a corporation,
such partnership, limited liability company or other applicable like action, on the part of such Investor. Each Transaction Document
executed by such Investor has been duly executed by such Investor, and when delivered by such Investor in accordance with the
terms hereof, will constitute the valid and legally binding obligation of such Investor, enforceable against it in accordance
with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by
other equitable principles of general application.


 




    	 	12 	 



    	 



    


 


(b)Investment
Intent. Such Investor is acquiring the Shares as principal for its own account and not with a view to or for distributing
or reselling such Shares or any part thereof, without prejudice, however, to such Investor’s right at all times to sell
or otherwise dispose of all or any part of such Shares in compliance with applicable federal and state securities laws. Subject
to the immediately preceding sentence, nothing contained herein shall be deemed a representation or warranty by such Investor
to hold the Shares for any period of time. Such Investor is acquiring the Shares hereunder in the ordinary course of its business.
Such Investor does not have any agreement or understanding, directly or indirectly, with any Person to distribute any of the Shares.


 


(c)Investor
Status. Such Investor is not a registered broker-dealer under Section 15 of the Exchange Act. Such Investor has such experience
in business and financial matters that it is capable of evaluating the merits and risks of an investment in the Shares. Such Investor
acknowledges that an investment in the Shares is speculative and involves a high degree of risk. At the time such Investor was
offered the Shares, it was, and at the date hereof it is, an “accredited investor” as defined in Rule 501(a) under
the Securities Act, and such Investor has completed and executed the Investor Questionnaire attached as Exhibit C to this
Agreement.


 


(d)General
Solicitation. Such Investor is not purchasing the Shares as a result of any advertisement, article, notice, meeting, or other
communication regarding the Shares published in any newspaper, magazine or similar media or broadcast over television or radio
or presented at any seminar or any other general solicitation or general advertisement.


 


(e)Access
to Information. Such Investor acknowledges that it has reviewed the Disclosure Materials and has been afforded (i) the opportunity
to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the
terms and conditions of the offering of the Shares and the merits and risks of investing in the Shares; (ii) access to information
about the Company and the Subsidiaries and their respective financial condition, results of operations, business, properties,
management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional
information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed
investment decision with respect to the investment. Neither such inquiries nor any other investigation conducted by or on behalf
of such Investor or its representatives or counsel shall modify, amend or affect such Investor’s right to rely on the truth,
accuracy and completeness of the Disclosure Materials and the Company’s representations and warranties contained in the
Transaction Documents.


 


(f)Certain
Trading Activities. Such Investor has not directly or indirectly, nor has any Person acting on behalf of or pursuant to any
understanding with such Investor, engaged in any transactions in the securities of the Company (including, without limitations,
any Short Sales involving the Company’s securities) since the earlier to occur of (1) the time that such Investor was first
contacted by the Company, or any other Person acting on behalf of the Company regarding an investment in the Company and (2) the
30th day prior to the date of this Agreement. Such Investor covenants that neither it nor any Person acting on its
behalf or pursuant to any understanding with it will engage in any transactions in the securities of the Company (including Short
Sales) prior to the time that the transactions contemplated by this Agreement are publicly disclosed.


 




    	 	13 	 



    	 



    


 


(g)Independent
Investment Decision. Such Investor has independently evaluated the merits of its decision to purchase the Shares pursuant
to the Transaction Documents, and such Investor confirms that it has not relied on the advice of any other Investor’s business
and/or legal counsel in making such decision.


 


(h)Reliance
on Exemptions. The Investor understands that the Shares are being offered and sold to it in reliance upon specific exemptions
from the registration requirements of United States federal and state securities laws and that the Company is relying upon the
truth and accuracy of, and the Investor’s compliance with, the representations, warranties, agreements, acknowledgments
and understandings of the Investor set forth herein in order to determine the availability of such exemptions and the eligibility
of the Investor to acquire the Shares. All of the information which the Investor has provided to the Company is true, correct
and complete as of the date this Agreement is signed, and if there should be any change in such information prior to the Closing,
the Investor will immediately provide the Company with such information.


 


The
Company acknowledges and agrees that no Investor has made or makes any representations or warranties with respect to the transactions
contemplated hereby other than those specifically set forth in this Section 3.2.


 


ARTICLE
4.


OTHER
AGREEMENTS OF THE PARTIES


 


4.1.Transferability;
Certificate.


 


(a)The
Shares may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of the Shares
other than pursuant to an effective registration statement, the Company may require the transferor thereof to provide to the Company
an opinion of counsel selected by the transferor, the form and substance of which opinion shall be reasonably satisfactory to
the Company, to the effect that such transfer does not require registration of such transferred Shares under the Securities Act.


 


(b)Certificates
evidencing Shares will contain the following legend or a substantially similar legend, until such time as they are not required
to contain such a legend under the Securities Act:


 


THESE
SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO,
THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A
LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.
THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES.


 




    	 	14 	 



    	 



    


 


4.2. Securities
Laws Disclosure; Publicity. By (i) 9:30 a.m. (Eastern time) on the Trading Day following the Closing Date, the Company
shall issue a press release, disclosing the transactions contemplated by the Transaction Documents and the Closing and by
(ii) 5:30 p.m. (Eastern time) on the fourth Trading Day following the Closing Date, the Company will file a Current Report on
Form 8-K, disclosing the material terms of the Transaction Documents (and attach as exhibits thereto all existing Transaction
Documents) and the Closing. The Company covenants that following such disclosure, the Investors shall no longer be in
possession of any material, non-public information with respect to the Company or any Subsidiary. In addition, the Company
will make such other filings and notices in the manner and time required by the Commission and the Trading Market on which
the Common Stock is quoted.


 


ARTICLE
5.


CONDITIONS
PRECEDENT TO CLOSING


 


5.1. Conditions
Precedent to the Obligations of the Investors to Purchase Shares. The obligation of the Investors to acquire Shares at
the Closing is subject to the satisfaction or waiver by each Investor, at or before the Closing, of each of the following
conditions:


 


(a)Representations
and Warranties. The representations and warranties of the Company contained herein shall be true and correct as of the date
when made and as of the Closing as though made on and as of such date;


 


(b)Performance.
The Company shall have performed, satisfied and complied with all covenants, agreements and conditions required by the Transaction
Documents to be performed, satisfied or complied with by it at or prior to the Closing;


 


(c)No
Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any
of the transactions contemplated by the Transaction Documents, the PHMD APA or the PHMD Transaction Documents;


 


(d)Adverse
Changes. Since the date of execution of this Agreement, no event or series of events shall have occurred that reasonably could
have or result in a Material Adverse Effect or a material adverse change with respect to the Company or the Subsidiaries;


 


(e)PHMD
Closing. The PHMD Closing shall have occurred or shall occur simultaneously with the First Closing;


 


(f)Company
Deliverables. The Company shall have delivered the Company Deliverables in accordance with Section 2.3(b);


 




    	 	15 	 



    	 



    


 


(g)Approvals.
The Company shall have obtained any and all consents, permits, approvals, registrations and waivers necessary or appropriate
for consummation of the purchase and sale of the Shares and the consummation of the other transactions contemplated by the Transaction
Documents, all of which shall be in full force and effect;


 


(h)Stop
Orders. No stop order or suspension of trading shall have been imposed by the Commission or any other governmental or regulatory
body having jurisdiction over the Company or the market(s) where the Common Stock is listed or quoted, with respect to public
trading in the Common Stock;


 


(i)Termination.
This Agreement shall not have been terminated as to such Investor in accordance with Section 6.5.


 


5.2. Conditions
Precedent to the Obligations of the Company to Sell Shares. The obligation of the Company to sell Shares at the Closing
is subject to the satisfaction or waiver by the Company, at or before the Closing, of each of the following
conditions:


 


(a)Representations
and Warranties. The representations and warranties of each Investor contained herein shall be true and correct in all material
respects as of the date when made and as of the Closing Date as though made on and as of such date;


 


(b)Performance.
Each Investor shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions
required by the Transaction Documents to be performed, satisfied or complied with by such Investor at or prior to the Closing;


 


(c)No
Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any
of the transactions contemplated by the Transaction Documents;


 


(d)PHMD
Closing. The PHMD Closing shall have occurred or shall occur simultaneously with the First Closing;


 


(e)Investor
Deliverables. Each Investor shall have delivered this Agreement, the Escrow Agreement and the Registration Rights Agreement,
each duly executed by such Investor and a completed Selling Holder Questionnaire (as defined in the Registration Rights Agreement)
and Investor Questionnaire in the form attached as Exhibit C to this Agreement.


 


(f)Termination.
This Agreement shall not have been terminated as to such Investor in accordance with Section 6.5.


 


ARTICLE
6.


MISCELLANEOUS


 


6.1. Fees
and Expenses. Each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any,
and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance
of the Transaction Documents; provided, however, that the Company shall reimburse an Investor who engaged the law firm of
Olshan Frome Wolosky LLP to represent such Investor for documented legal fees in an amount not to exceed $10,000. The Company
shall pay all stamp and other taxes and duties levied in connection with the sale of the Shares.


 




    	 	16 	 



    	 



    

 


 


6.2. Entire
Agreement. The Transaction Documents, together with the Exhibits and Schedules thereto, contain the entire understanding
of the parties with respect to the subject matter hereof and supersede all prior agreements, understandings, discussions and
representations, oral or written, with respect to such matters, which the parties acknowledge have been merged into such
documents, exhibits and schedules.


 


6.3. Notices.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing
and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is
delivered via (i) facsimile (provided the sender receives a machine-generated confirmation of successful transmission) at the
facsimile number specified in this Section or (ii) electronic mail (i.e., Email) prior to 6:30 p.m. (Eastern) on a Trading
Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via (i) facsimile
at the facsimile number specified in this Section or (ii) electronic mail (i.e., Email) on a day that is not a Trading Day or
later than 6:30 p.m. (Eastern) on any Trading Day, or (c) the Trading Day following the date of mailing, if sent by U.S.
nationally recognized overnight courier service, or (d) upon actual receipt by the party to whom such notice is required to
be given, if sent by any means other than facsimile or Email transmission. The address for such notices and communications
shall be as follows:


 


	 	If
    to the Company: 	489
    Devon Park Drive, Suite 315
	 	 	Wayne,
    PA 19087
	 	 	Attention:
    Richard Ransom
	 	 	Facsimile:
	 	 	Email:
    Ransom@ictvbrands.com
	 	 	 
	 	With
    a copy to:	BEVILACQUA
    PLLC
	 	 	1629
    K Street, NW, Suite 300
	 	 	Washington,
    DC 20006
	 	 	Attention:
    Louis A. Bevilacqua, Esq.
	 	 	Email:
    lou@bevilacquapllc.com
	 	 	 
	 	If
    to the Investor:	To
    the Investor’s address as specified on Investor’s Signature Page.


 


or
such other address as may be designated in writing hereafter, in the same manner, by such Person.


 


6.4. Amendments;
Waivers. No provision of this Agreement may be waived or amended except in a written instrument signed, in the case of
an amendment, by the Company and the holders of a majority of the Shares sold to Investors under this Agreement or, in the
case of a waiver, by the party against whom enforcement of any such waiver is sought (and if such party is the Investors,
then by the holders of a majority of the Shares sold to Investors under this Agreement). No waiver of any default with
respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future
or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any
delay or omission of either party to exercise any right hereunder in any manner impair the exercise of any such
right.


 




    	 	17 	 



    	 



    


 


6.5. Termination
.. This Agreement may be terminated prior to Closing:


 


(a)by
written agreement of the Investors holding a majority of the Shares sold to Investors under this Agreement and the Company;


 


(b)automatically
upon the termination of the PHMD APA; and


 


(c)by
the Company or an Investor (as to itself but no other Investor) upon written notice to the other, if the Closing shall not have
taken place by 6:30 p.m. Eastern time on or before the Outside Date; provided, that the right to terminate this Agreement under
this Section 6.5(c) shall not be available to any Person whose failure to comply with its obligations under this Agreement has
been the cause of or resulted in the failure of the Closing to occur on or before such time; provided however that such termination
will not affect the right of any party to sue for any breach by any other party (or parties).


 


In
the event of a termination pursuant to this Section, the Company shall promptly notify all non-terminating Investors.


 


6.6. Construction.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or
affect any of the provisions hereof. The language used in this Agreement will be deemed to be the language chosen by the
parties to express their mutual intent, and no rules of strict construction will be applied against any party. This Agreement
shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or
disfavoring any party by virtue of the authorship of any provisions of this Agreement or any of the Transaction
Documents.


 


6.7. Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written
consent of the Investors. Any Investor may assign any or all of its rights under this Agreement to any Person to whom such
Investor assigns or transfers any Shares, provided such transferee agrees in writing to be bound, with respect to the
transferred Shares, by the provisions hereof that apply to the “Investors.”


 


6.8. No
Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective
successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other
Person.


 




    	 	18 	 



    	 



    


 


6.9.Mediation;
Arbitration and Governing Law. In the event of a dispute between any of the Parties arising under or relating in any way whatsoever
to this Agreement, the disputing Parties shall attempt to resolve it through good faith negotiation. If the dispute is not resolved
through such negotiation, then the disputing Parties shall attempt to resolve it through mediation in the State of New York, USA,
with a neutral, third-party mediator mutually agreed upon by the disputing Parties. Unless otherwise agreed by the disputing Parties,
the costs of mediation shall be shared equally. If the dispute is not resolved through mediation, then upon written demand by
one of the disputing Parties it shall be referred to a mutually agreeable arbitrator. The arbitration process shall be conducted
in accordance with the laws of the United States of America and the State of New York, except as modified herein. Venue for the
arbitration hearing shall be the State of New York, USA. All remedies, legal and equitable, available in court shall also be available
in arbitration. The arbitrator’s decision shall be final and binding, and judgment may be entered thereon in a court of
competent jurisdiction. This Agreement shall be interpreted and enforced in accordance with the laws of the United States of America
and the State of New York, without regard to conflict of law principles thereof. In any dispute arising out of or relating in
way whatsoever to this Agreement, including arbitration, the substantially prevailing Party shall be entitled to recover its costs
and attorney fees from the other disputing Parties.


 


6.10. Survival.
The representations, warranties, agreements and covenants contained herein shall survive the Closing and the delivery of the
Shares for 18 months following the Closing Date.


 


6.11. Execution.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the
same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party,
it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by
facsimile or e-mail transmission, such signature shall create a valid and binding obligation of the party executing (or on
whose behalf such signature is executed) with the same force and effect as if such facsimile or e-mail signature page were an
original thereof.


 


6.12. Severability.
If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and enforceability of
the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties
will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so agreeing,
shall incorporate such substitute provision in this Agreement.


 


6.13. Remedies.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each
of the Investors and the Company will be entitled to specific performance under the Transaction Documents. The parties agree
that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations described
in the foregoing sentence and hereby agrees to waive in any action for specific performance of any such obligation the
defense that a remedy at law would be adequate.


 


[Signature
page follows]


  




    	 	19 	 



    	 



    


 


IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective
authorized signatories as of the date first indicated above.


 


	 	COMPANY:
	 	 
	 	ICTV
    Brands Inc. 
	 	 
	 	By:	/s/
    Richard Ransom
	 	Name:	Richard
    Ransom
	 	Title:	President
    
	 	 
	 	INVESTORS:
	 	 
	 	The
    Investors executing the Signature Page in the form attached hereto as Annex A and delivering the same to the Company
    or its agents shall be deemed to have executed this Agreement and agreed to the terms hereof.


  




    	 	 	 



    	 



    


 


Annex
A


 


Securities
Purchase Agreement


Investor
Counterpart Signature Page


 


The
undersigned, desiring to: (i) enter into this Securities Purchase Agreement, dated as of October 4, 2016 (the “Agreement”),
between the undersigned, ICTV Brands Inc., a Nevada corporation (the “Company”), and the other parties thereto,
in or substantially in the form furnished to the undersigned and (ii) purchase the Shares of the Company appearing below, hereby
agrees to purchase such Shares from the Company as of the Closing and further agrees to join the Agreement as a party thereto,
with all the rights and privileges appertaining thereto, and to be bound in all respects by the terms and conditions thereof.


 


IN
WITNESS WHEREOF, the undersigned has executed the Agreement as of October 4, 2016.


 


	 	Name
    and Address, Fax No. and Social Security No./EIN of Investor:
	 	 
	 	LeoGroup
        Private Debt Facility, L.P.

        100
        Wood Avenue South, Suite #209

        Iselin,
        NJ 08830

        Attn:
        Matthew J. Allain

         

        Fax
        No.: 732-523-2243

         

        Soc.
        Sec. No./EIN: ________________

	 	 
	 	If
    a partnership, corporation, trust or other business entity: 
	 	 
	 	By:	/s/
    Matthew J. Allain
	 	Name:	Matthew
    J. Allain
	 	Title:	Manager
	 	 
	 	If
    an individual: 
	 	 
	 	Signature:
    _________________________________
	 	 
	 	Investment
    Amount: $1,500,000
	 	 
	 	Amount
    of Shares to be Purchased: 4,411,765
	 	 
	 	Account
        Registration Type (check one) 

         

        [  ]
        Individual Account

         

        [  ]
        Joint Account

         

        [  ]
        Individual Retirement Accout

         

        [X]
        Corporation/Pratnership/Other

         

        [  ]
        Trust






 






    	 	 	 



    	 



    

 


Annex
A


 


Securities
Purchase Agreement


Investor
Counterpart Signature Page


 


The
undersigned, desiring to: (i) enter into this Securities Purchase Agreement, dated as of October 4, 2016 (the “Agreement”),
between the undersigned, ICTV Brands Inc., a Nevada corporation (the “Company”), and the other parties thereto,
in or substantially in the form furnished to the undersigned and (ii) purchase the Shares of the Company appearing below, hereby
agrees to purchase such Shares from the Company as of the Closing and further agrees to join the Agreement as a party thereto,
with all the rights and privileges appertaining thereto, and to be bound in all respects by the terms and conditions thereof.


 


IN
WITNESS WHEREOF, the undersigned has executed the Agreement as of October 4, 2016.


 


	 	Name
    and Address, Fax No. and Social Security No./EIN of Investor:
	 	 
	 	Sandra
        F. Pessin

        366
        Madison Avenue, 14th Floor

        New
        York, NY 10017

         

        Fax
        No.: _______________

         

        Soc.
        Sec. No./EIN: ________________

	 	 
	 	If
a partnership, corporation, trust or other business entity: 

	 	 	 	 
	 	By:	 	 
	 	Name:	 	 
	 	Title:	 	 
	 	 
	 	If
an individual: 

	 	 	 
	 	Signature:
    	/s/
    Sandra F. Pessin	 
	 	 
	 	Investment
    Amount: $1,200,000
	 	 
	 	Amount
    of Shares to be Purchased: 3,529,412
	 	 
	 	Account
        Registration Type (check one) 

         

        [X]
        Individual Account

         

        [  ]
        Joint Account

         

        [  ]
        Individual Retirement Accout

         

        [  ]
        Corporation/Pratnership/Other

         

        [  ]
        Trust



 




    	 	 	 



    	 



    


 


Annex
A


 


Securities
Purchase Agreement


Investor
Counterpart Signature Page


 


The
undersigned, desiring to: (i) enter into this Securities Purchase Agreement, dated as of October 4, 2016 (the “Agreement”),
between the undersigned, ICTV Brands Inc., a Nevada corporation (the “Company”), and the other parties thereto,
in or substantially in the form furnished to the undersigned and (ii) purchase the Shares of the Company appearing below, hereby
agrees to purchase such Shares from the Company as of the Closing and further agrees to join the Agreement as a party thereto,
with all the rights and privileges appertaining thereto, and to be bound in all respects by the terms and conditions thereof.


 


IN
WITNESS WHEREOF, the undersigned has executed the Agreement as of October 4, 2016.


 


	 	Name
    and Address, Fax No. and Social Security No./EIN of Investor:
	 	 
	 	Brian
        L. Pessin

        310
        E 75th Street, Apt 2a

        New
        York, NY 10021

         

        Fax
        No.: _______________

         

        Soc.
        Sec. No./EIN: ________________

	 	 
	 	If
    a partnership, corporation, trust or other business entity: 
	 	 
	 	By:	 	 
	 	Name:	 	 
	 	Title:	 	 
	 	 
	 	If
    an individual: 
	 	 
	 	Signature:	/s/
    Brian L. Pessin	 
	 	 
	 	Investment
    Amount: $300,000
	 	 
	 	Amount
    of Shares to be Purchased: 882,353
	 	 
	 	Account
        Registration Type (check one)

         

        [X]
        Individual Account

         

        [  ]
        Joint Account

         

        [  ]
        Individual Retirement Accout

         

        [  ]
        Corporation/Pratnership/Other

         

        [  ]
        Trust






 






    	 	 	 



    	 



    

 





EXHIBIT
A


 


SCHEDULE
OF INVESTORS


 


	Name	 	Investment Amount	 	 	Number of Shares	 
	LeoGroup Private Debt Facility, L.P.	 	$	1,500,000.00	 	 	 	4,411,765	 
	Sandra F. Pessin	 	$	1,200,000.00	 	 	 	3,529,412	 
	Brian L. Pessin	 	$	300,000.00	 	 	 	882,353	 
	TOTALS	 	$	3,000,000.00	 	 	 	8,823,530